mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.4 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |